Society
Driving innovation in clinical research since 2012
We are a full-service Contract Research Organisation (CRO) specialising in the management of clinical studies and Real-World Evidence (RWE) projects, the development and validation of proprietary digital platforms, Digital Health solutions and advanced data management.
For more than ten years, we have supported pharmaceutical and biotechnology companies, medical device manufacturers and institutions by combining scientific, regulatory and technological expertise to ensure high standards of quality, regulatory compliance and operational efficiency.
Through our proprietary ICE® Platform, we support study management throughout the entire lifecycle, from the initial planning phase to the final archiving of documentation and data.
Our Mission
To contribute to the development of new therapies through services and technologies that support the entire clinical research lifecycle, ensuring:
- scientific quality and data integrity;
- compliance with national and international regulatory requirements;
- operational efficiency and process optimisation;
- a consultative approach focused on the client’s objectives;
- sustainable and validated technological innovation.
Our Evolution
-
2012
Advice Pharma is founded as a software company specialising in Research and Development (R&D).
-
2013
Advice Pharma opens its first office at PoliHub, the innovation park and start-up incubator of the Politecnico di Milano
-
2014
Advice Pharma completes its CRO self-certification with the Italian national regulatory authority, AIFA.
-
2017
The first version of ICE, Advice Pharma’s proprietary EDC and eCRF software, is released as a SaaS solution.
-
2018
Advice Pharma achieves ISO 9001 certification for the development of IT systems.
-
2020
Advice Pharma achieves ISO 13485 certification for the development of software as a medical device.
-
2021
Advice Pharma undergoes an inspection by the Italian national regulatory authority, AIFA.
-
2022
Advice Pharma becomes part of the Sapio Group.
-
2023
Advice Pharma opens offices in Paris and Berlin.
-
2024
- Advice Pharma achieves ISO 27001 certification for information security.
Our Operating Model
Scientific Rigour
We apply established methodologies, international standards and Quality by Design processes to ensure reliable results, complete traceability of activities and regulatory compliance.
People-Centred Approach
We design services and digital solutions around the needs of all stakeholders involved in clinical research, including sponsors, investigators, clinical sites, clinical research associates, data managers and patients.
Technological Innovation
We invest in developing proprietary software and digital tools designed to improve data quality, facilitate information integration and increase process efficiency.
A Journey of Continuous Innovation
Our journey began with the development of ICE® eCRF, a solution designed to simplify and digitise clinical data collection.
Over time, we expanded our expertise and technological capabilities, ultimately developing ICE® Platform, an integrated digital ecosystem designed to provide comprehensive support for clinical research management.
Our Key Figures
Over 120 projects supported
Clinical studies, observational studies and RWE programmes managed in accordance with high quality standards.
Over 250 clinical sites activated
An established network of partnerships that facilitates the efficient start-up and coordination of clinical studies.
100% GxP-validated systems
Platforms and applications developed and maintained in compliance with applicable regulatory requirements.
Proprietary digital solutions
ICE® Platform, data anonymisation services, Long-Term Storage and RITA® – Remote Intelligence for Therapeutic Adherence, a digital medicine solution designed to support treatment adherence.
Multidisciplinary team
Professionals specialising in Clinical Operations, Project Management, Data Management, Biostatistics, Quality Assurance, Regulatory Affairs, Digital Health and Software Development.
Our Commitment
Our Commitment
We are committed to creating value for clinical research through quality, reliability and innovation. Our work contributes to the development of increasingly accessible and effective therapies for the benefit of patients and the healthcare system as a whole